HSP90B2P and lung carcinoma: By inhibiting IL-1β, HSP (100 μM) decreases COX-2 expression and its regulation in translation level in A549 lung cancer cell and PGE2 synthesis, indicating its anti-inflammatory and anti-cancer potential in human lung cancer cells [70].